The World Health Organization on Thursday granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution. WHO said the PfizerBioNTech vaccine was the first to receive its Emergency validation since the novel coronavirus first broke out in China a year ago. WHO said its emergency use listing opens the way for regulators in different countries to approve the import and distribution of the vaccine.